Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane-based doublet in cancer of unknown primary
NCT02607202Phase 2Completed
- Sponsor
- Fondazione del Piemonte per l'Oncologia
- Start
- Mar 2015
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in cancer of unknown primary (CUP), sponsored by Fondazione del Piemonte per l'Oncologia. Started Mar 2015; status: completed.
02
Drugs
paclitaxel
03
Conditions
cancer of unknown primary (CUP)
Beyond the preview
Go deeper on NCT02607202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607202.